- Home
- ADMA
ADMA
ADMA Biologics Inc
as of 12-04-2025 3:45pm EST
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | RAMSEY |
| Market Cap: | 4.1B | IPO Year: | N/A |
| Target Price: | $28.50 | AVG Volume (30 days): | 3.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.86 | EPS Growth: | 205.35 |
| 52 Week Low/High: | $13.50 - $25.67 | Next Earning Date: | 11-05-2025 |
| Revenue: | $488,559,000 | Revenue Growth: | 27.63% |
| Revenue Growth (this year): | 21.08% | Revenue Growth (next year): | 25.98% |
AI-Powered ADMA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of ADMA Biologics Inc (ADMA)
President and CEO
Avg Cost/Share
$16.13
Shares
21,000
Total Value
$338,730.00
Owned After
2,031,850
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Grossman Adam S | ADMA | President and CEO | Sep 15, 2025 | Sell | $16.13 | 21,000 | $338,730.00 | 2,031,850 |
Compare ADMA vs Leading Stocks
See how ADMA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ADMA ADMA Biologics Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.